Pharmaterials
2000
FOUNDED
M&A
STATUS
31-40
EMPLOYEES
Buyout/LBO
LATEST DEAL TYPE
2
FINANCING ROUNDS
Description
Provider of medical contract development and manufacturing services. The company uses 13 GMP manufacturing suites to offer characterization and optimization of drug substance physical forms, development of preclinical and clinical formulations, clinical trial manufacturing and global drug product supply services in the United Kingdom.
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Drug Discovery
Parent Company
Primary Office
- Unit B, 5 Boulton Road
- Reading RG2 0NH
- England, United Kingdom
+44 0118 000 0000
Pharmaterials Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Pharmaterials‘s full profile, request access.
Request full access to PitchBookPharmaterials Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Pharmaterials‘s full profile, request access.
Request full access to PitchBookPharmaterials Executive Team (3)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Syed Abidi Ph.D | Chief Executive Officer | ||
| David Matkin | Chief Scientific Officer |
1 Former Executive
You’re viewing 2 of 3 executives. Get the full list »